Therapeutic angiogenesis is an attractive strategy to treat patients suffering from ischaemic conditions and vascular endothelial growth factor-A (VEGF) is the master regulator of blood vessel growth. However, VEGF can induce either normal or aberrant angiogenesis depending on its dose localized in the microenvironment around each producing cell in vivo and on the balanced stimulation of platelet-derived growth factor-BB (PDGF-BB) signalling, responsible for pericyte recruitment. At the doses required to induce therapeutic benefit, VEGF causes new vascular growth essentially without sprouting, but rather through the alternative process of intussusception, or vascular splitting. In the present article, we briefly review the therapeutic implications of controlling VEGF dose on one hand and pericyte recruitment on the other, as well as the key features of intussusceptive angiogenesis and its regulation.
Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis
- Views Icon Views
- Share Icon Share
Roberto Gianni-Barrera, Mariateresa Bartolomeo, Brigitte Vollmar, Valentin Djonov, Andrea Banfi; Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis. Biochem Soc Trans 1 December 2014; 42 (6): 1637–1642. doi: https://doi.org/10.1042/BST20140234
Download citation file: